# Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56

> **NCT05488418** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 255 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic
- Depressive Disorder, Major
- Anxiety Disorder

## Interventions

- **OTHER:** Clinical, cognitive and biological tests

## Key facts

- **NCT ID:** NCT05488418
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05488418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05488418, "Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05488418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*